Rezolute News

Rezolute Analyst Ratings

BenzingaApr 19 12:25 ET

Rezolute Analyst Ratings

BenzingaApr 18 07:59 ET

Optimistic Buy Rating for Rezolute's RZ402 Drug Candidate Amid Promising DME Treatment Prospects

TipRanksApr 18 00:35 ET

Rezolute Analyst Ratings

BenzingaApr 9 11:34 ET

Rezolute Analyst Ratings

BenzingaMar 7 07:29 ET

Analysts Offer Insights on Healthcare Companies: PepGen Inc. (PEPG), ITeos Therapeutics (ITOS) and Rezolute (RZLT)

TipRanksMar 7 06:30 ET

Analysts Offer Insights on Healthcare Companies: Rezolute (RZLT) and KalVista Pharmaceuticals (KALV)

TipRanksFeb 14 06:20 ET

Rezolute Analyst Ratings

BenzingaFeb 14 06:19 ET

Buy Rating Affirmed for Rezolute Amidst Promising Clinical Developments and Stable Financials

TipRanksFeb 14 00:15 ET

Buy Rating Affirmed for Rezolute's RZ358 Based on Untapped Market Potential and Therapeutic Efficacy

TipRanksFeb 8 06:19 ET

Rezolute's Promising Drug Pipeline and Market Position Validate Buy Rating: An Analysis of RZ358 and RZ402 Potential

TipRanksNov 17, 2023 06:22 ET

JMP Securities Maintains Market Outperform on Rezolute, Lowers Price Target to $7

BenzingaNov 14, 2023 11:31 ET

Rezolute Analyst Ratings

BenzingaNov 14, 2023 11:30 ET

Analysts Are Bullish on Top Healthcare Stocks: Benitec Biopharma (BNTC), Rezolute (RZLT)

TipRanksNov 14, 2023 00:30 ET

Cantor Fitzgerald Reiterates Overweight on Rezolute, Maintains $5 Price Target

BenzingaSep 19, 2023 09:11 ET

Rezolute Analyst Ratings

BenzingaSep 19, 2023 09:10 ET

HC Wainwright & Co. Reiterates Buy on Rezolute, Maintains $14 Price Target

BenzingaSep 18, 2023 06:47 ET

Rezolute Analyst Ratings

BenzingaSep 18, 2023 06:46 ET

Analysts Offer Insights on Healthcare Companies: Rezolute (RZLT), TG Therapeutics (TGTX) and Harpoon Therapeutics (HARP)

TipRanksSep 18, 2023 06:20 ET

JMP Securities Reiterates Market Outperform on Rezolute, Maintains $8 Price Target

BenzingaSep 15, 2023 08:30 ET